Genetic Testing for Personalized Medicine

A relatively new form of genetic testing called, pharmacogenetics, is being used to improve efficacy and reduce the adverse effects of psychiatric medications. To discuss what pharmacogenetics is and how it’s used in the behavioral health industry is Dr. Jay Lombard, the cofounder, Chief Scientific Officer and Medical Director at Genomind, and Dr. Stephen M. Stahl, an internationally renowned psychiatrist, researcher and professor of psychiatry with expertise in psychopharmacology.